Phase 2 Bronchopulmonary Dysplasia Clinical Trials
11 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–11 of 11 trials
Recruiting
Phase 2
Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below
Bronchopulmonary Dysplasia
International Peace Maternity and Child Health Hospital29 enrolled1 locationNCT07561125
Recruiting
Phase 2
IVIG Trial for the Treatment of Bronchopulmonary Dysplasia
Bronchopulmonary Dysplasia
International Peace Maternity and Child Health Hospital20 enrolled1 locationNCT06925360
Recruiting
Phase 1Phase 2
PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
Critical IllnessBronchopulmonary Dysplasia (BPD)Premature Births
Duke University28 enrolled4 locationsNCT07101640
Recruiting
Phase 2Phase 3
Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
Bronchopulmonary Dysplasia
Airway Therapeutics, Inc.366 enrolled20 locationsNCT06897839
Recruiting
Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
Bronchopulmonary Dysplasia
OHB Neonatology Ltd.338 enrolled66 locationsNCT03253263
Recruiting
Phase 2
Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.
Bronchopulmonary Dysplasia
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal75 enrolled7 locationsNCT06270199
Recruiting
Phase 1Phase 2
Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulmonary Dysplasia(BPD) in Premature Infants
BPD - Bronchopulmonary Dysplasia
The Children's Hospital of Zhejiang University School of Medicine10 enrolled1 locationNCT06788470
Recruiting
Phase 1Phase 2
Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants
Bronchopulmonary Dysplasia
EXO Biologics S.A.265 enrolled8 locationsNCT06279741
Recruiting
Phase 1Phase 2
Different Levels of BiPAP
Bronchopulmonary Dysplasia
King's College Hospital NHS Trust21 enrolled1 locationNCT06421519
Suspended
Phase 2Phase 3
The Torpido2 Study: Targeted Oxygenation in the Respiratory care of Premature Infants at Delivery: Effects on developmental Outcome
Oxidative stress in premature infantsBronchopulmonary dysplasia in premature infantsResuscitation of premature infants+2 more
University of Sydney1,200 enrolled5 locationsACTRN12615000115538
Recruiting
Phase 2Phase 3
The To2rpido Study: Targeted Oxygenation in the Resuscitation of Premature Infants and their Developmental Outcome
Oxidative stress in premature infantsBronchopulmonary dysplasia in premature infantsResuscitation in premature infants+1 more
The Royal Hospital for Women1,892 enrolled1 locationACTRN12610001059055